Important information on the revised information for healthcare professionals for Voluven 6% balanced, solution for infusion, and the revised training material as part of the controlled access programme (CAP)

14.08.2024

New transitional provisions

EU IVDR amendment: Equivalence with EU Regulation on Medical Devices ensured

14.08.2024

Update of information sheet on non-standardised medicinal products and on the list of non-standardised medicinal products and medicinal product groups with a manufacturing process subject to mandatory authorisation according to Annex 3 TPLO

The revised information sheet is valid with effect from 01 July 2024

13.08.2024

DHPC – Rabipur (virus rabiei inactivatus)

Berichte über Partikel nach der Rekonstitution - Empfehlungen zur Minimierung des Risikos für Partikel

13.08.2024

Out-of-Stock – Bydureon BCise, Depot-lnjektionssuspension Autoinjektor

Befristete Bewilligung zum Vertrieb in englischer Aufmachung

09.08.2024

Vigilance Assessor/in Risk Management (60-80%)

Job advertisement | Abteilung Arzneimittelsicherheit

08.08.2024

Swissmedic Journal

Latest edition
Swissmedic Journal Juli 2024

06.08.2024

swissdamed “Actors” module now available

The first module of the swissdamed medical devices database is online today.

06.08.2024

Public Summary SwissPAR – Welireg®

First authorisation

05.08.2024

Sarco suicide capsule does not fulfil definition of a therapeutic product

Swissmedic has made an initial assessment of the Sarco suicide capsule according to therapeutic products legislation

02.08.2024

Swissmedic authorises dengue fever vaccine

Qdenga (powder and solvent for solution for injection in a pre-filled syringe) can be placed on the market in Switzerland

31.07.2024

Public Summary SwissPAR – Qarziba®

First authorisation

Last modification 01.12.2017

Top of page

Main Navigation

Search

Breadcrumb

RSS Feed Content – New on the website